The COVID-19 crisis has created an unprecedented interest in how diagnostics, new treatments and vaccines are discovered, developed, regulated and used. At the same time, the European Commission has launched the Pharmaceutical Strategy, reviews of the Orphan and Paediatric Regulations, the IP Action Plan and other initiatives that have an impact on patients, on science, innovation, our resilience and economic growth. In our search for new diagnostics, treatments and vaccines we never stop asking questions, and we don't expect you to either. You can join the conversation and ask the questions that are important to you. #WeWontRest in our search for answers and we don't expect you to.

Join the conversationWho decides the price of a medicine? Is the pharmaceutical industry making too much money? Listen to our podcasts and join the conversation. 

Do you have a suggestion about the next topic? Let us know by inserting it here.

Discover our 19 Conversations podcast series